Submission Details
| 510(k) Number | K052519 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 14, 2005 |
| Decision Date | November 30, 2006 |
| Days to Decision | 442 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K052519 is an FDA 510(k) clearance for the SPECTRAL WEST NILE VIRUS IGM STATUS TEST, a Elisa, Antibody, West Nile Virus (Class II — Special Controls, product code NOP), submitted by Spectral Diagnostics, Inc. (Toronto, Ontario, CA). The FDA issued a Cleared decision on November 30, 2006, 442 days after receiving the submission on September 14, 2005. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3940.
| 510(k) Number | K052519 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 14, 2005 |
| Decision Date | November 30, 2006 |
| Days to Decision | 442 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | NOP — Elisa, Antibody, West Nile Virus |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3940 |
| Definition | The West Nile Virus Elisa Is Intended For The Detection Of Igg And Igm Antibodies To West Nile Virus. Specimens May Be Serum Or Cerebral Spinal Fluid From Symptomatic Patients. |